# Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)

> **NCT04351919** · PHASE4 · WITHDRAWN · sponsor: **Abderrahmane Mami Hospital**

## Conditions studied

- Patients With COVID19

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT04351919
- **Lead sponsor:** Abderrahmane Mami Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-05
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-07-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** \- Interest in the use of HCQ is controversial.
- **Last updated:** 2020-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04351919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04351919, "Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04351919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*